QSAM Qsam Biosciences Inc

USD 6.70 0.00 0
Icon

Qsam Biosciences Inc (QSAM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 6.70

0.00 (0.00)%

USD 0.02B

6.20K

N/A

N/A

Icon

QSAM

Qsam Biosciences Inc (USD)
COMMON STOCK | NSD
USD 6.70
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 6.70

Qsam Biosciences Inc (QSAM) Stock Forecast

N/A

Based on the Qsam Biosciences Inc stock forecast from 0 analysts, the average analyst target price for Qsam Biosciences Inc is not available over the next 12 months. Qsam Biosciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Qsam Biosciences Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Qsam Biosciences Inc’s stock price was USD 6.70. Qsam Biosciences Inc’s stock price has changed by +0.00% over the past week, +21.82% over the past month and +59.52% over the last year.

No recent analyst target price found for Qsam Biosciences Inc
No recent average analyst rating found for Qsam Biosciences Inc

Company Overview Qsam Biosciences Inc

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement wit...Read More

https://qsambio.com

Plaza 1, Austin, TX, United States, 78759

4

December

USD

USA

Adjusted Closing Price for Qsam Biosciences Inc (QSAM)

Loading...

Unadjusted Closing Price for Qsam Biosciences Inc (QSAM)

Loading...

Share Trading Volume for Qsam Biosciences Inc Shares

Loading...

Compare Performance of Qsam Biosciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for QSAM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Qsam Biosciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD90.49B 26.38 17.57

ETFs Containing QSAM

Symbol Name QSAM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Qsam Biosciences Inc (QSAM) Stock

Stock Target Advisor's fundamental analysis for Qsam Biosciences Inc's stock is Bearish.

Unfortunately we do not have enough data on QSAM's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on QSAM's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on QSAM's stock to indicate if its overvalued.

The last closing price of QSAM's stock was USD 6.70.

The most recent market capitalization for QSAM is USD 0.02B.

Unfortunately we do not have enough analyst data on QSAM's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Qsam Biosciences Inc's stock.

As per our most recent records Qsam Biosciences Inc has 4 Employees.

Qsam Biosciences Inc's registered address is Plaza 1, Austin, TX, United States, 78759. You can get more information about it from Qsam Biosciences Inc's website at https://qsambio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...